Looking for volunteers
Thoracic Surgery by the Medtronic Hugo™ Robotic System
NCT06669104 · Chinese University of Hong Kong · Updated 21 Oct 2026
- What is being tested
- Medtronic Hugo™ surgical robotic system
- For
- Thoracic Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 50 people. The full rules are on the registry page.
- Where
- Hong Kong
- When
- Starts or started 1 May 2025, ends 31 Aug 2027. Registered 1 Nov 2024.
- Results
- None posted yet.
In the researchers' words
The introduction of robot-assisted surgery is one of the biggest breakthroughs in surgery, and represents the most significant advancement in minimally invasive surgery of recent decades. One of the first surgical uses of the robot was in orthopaedics, neurosurgery and cardiac surgery. However, it's use has now been well recognized in thoracic surgical procedures ranging from mediastinal tumour resection to complex major lung resections. Robotic surgery by the da Vinci Surgical System (Intuitive Surgical, Inc) has been one of the most commonly used robotic systems in surgery. The robotic system overcomes the limitations of the standard thoracoscopic approach and allows for precise dissection in a confined space. These advantages include stable operator-controlled camera, high- definition 3D magnified view of 10 to 12 times, articulating instruments with seven degrees of freedom, motion scaling, and tremor filtration. Recently the Medtronic Hugo™ surgical robotic system has passed the CE mark. This robotic platform, made up of modular surgical arms on wheeled carts, has started its operation in human in Latin America, Europe and the Asia-Pacific region. The Hugo™ system is designed to provide a lower barrier to entry for hospitals looking to expand their reach in robotic surgery. Compared to the platform by Intuitive Surgical, Hugo™can be customized with up to four…
Sites
- Prince of Wales HospitalHong Kong, Hong Kong
